I think the phrase 'a bird in the hand is worth 2 in the bush' is your answer.There is no need to spread management too thin (or our cash in hand) on further exploration until Hera is well on its way.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025